Cotización Gelteq - GELS

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Premium

Último Precio

2.24

Postura de Compra

2.19

Postura de Venta

2.30

Volume Operado de la Acción

4,681

2.20 Rango del Día 2.25

1.42 Rango de 52 semanas 5.50

Precio Anterior

2.23

Precio de Apertura

2.20

Hora

2.2831

Última hora de negociación

09:08:21

Volumen promedio (3 m)

548,799

Volumen financiero

US$ 10,409

Precio Promedio Ponderado

2.2236

Gelteq Launches SportsGel Brand and Signs Distribution Agreement with E-Commerce Solutions Company in Asia-Pacific Region, WPIC

NEW YORK, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a global biotechnology company that specializes in the formulation, development, and...

Gelteq Appoints Matthew Jones as Head of Sports Performance

NEW YORK, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a global biotechnology company that specializes in the formulation, development, and...

Gelteq Appoints Dr. Paul Wynne as Chief Scientific Officer to Propel Innovative Ingestible Gel Technology

NEW YORK, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a global biotechnology company that specializes in the formulation, development, and...

Gelteq Receives FDA Approval of its Suitability Petition for New Animal Drug

NEW YORK, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a clinical and biotechnology company focused on developing and commercializing white label...

Gelteq to Participate in the Benchmark Company 13th Annual Discovery Investor Conference

NEW YORK, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a clinical and science-based company that is focused on developing and commercializing...

Gelteq Announces Largest U.S. Customer Increases Initial Order by 50% to Meet Growing Market Demand

NEW YORK, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a clinical and science-based company that is focused on developing and commercializing...

Gelteq Announces 400,000 Units Enter into Production in November 2024

NEW YORK, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a clinical and science-based company focused on developing and commercializing white label...

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Gelteq Expands Operations in United States with Appointment of Adam Bendell as President of U.S. Operations to Scale Domestic Business

NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a clinical and science-based company that is focused on developing and commercializing...

Form NT 20-F - Notification of inability to timely file Form 20-F

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	-0.43	-16.1048689139	2.67	2.82	2.05	96709	2.34262121	CS
4	-0.16	-6.66666666667	2.4	2.84	1.87	491517	2.61752302	CS
12	0.63	39.1304347826	1.61	5.5	1.42	548799	3.40657494	CS
26	-1.76	-44	4	5.5	1.42	463294	3.38035663	CS
52	-1.76	-44	4	5.5	1.42	463294	3.38035663	CS
156	-1.76	-44	4	5.5	1.42	463294	3.38035663	CS
260	-1.76	-44	4	5.5	1.42	463294	3.38035663	CS

GELS - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Gelteq?

El precio actual de las acciones de Gelteq es US$ 2.24

¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Gelteq?

Gelteq ha negociado en un rango de US$ 1.42 a US$ 5.50 durante el último año

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
LIPOLipella Pharmaceuticals Inc	US$ 5.385 (108.72%)	61.08M
QNTMQuantum Biopharma Ltd	US$ 15.319 (78.54%)	10.7M
APPSDigital Turbine Inc	US$ 4.285 (68.70%)	31.8M
LTRYLottery com Inc	US$ 0.727 (48.40%)	13.47M
INVZWInnoviz Technologies Ltd	US$ 0.13 (43.49%)	27.28k
RETOReTo Eco Solutions Inc	US$ 0.4726 (-40.93%)	379.34k
AVGRAvinger Inc	US$ 0.3808 (-31.99%)	714.08k
SRTSSensus Healthcare Inc	US$ 6.17 (-31.37%)	956.7k
BTAIBioXcel Therapeutics Inc	US$ 0.2135 (-28.57%)	2.34M
PTIXProtagenic Therapeutics Inc	US$ 0.2698 (-27.98%)	389.95k
CYNCYNGN Inc	US$ 0.0808 (-1.46%)	67.43M
RIMEAlgorhythm Holdings Inc	US$ 0.0212 (1.44%)	64.4M
LIPOLipella Pharmaceuticals Inc	US$ 5.385 (108.72%)	61.09M
NVDANVIDIA Corporation	US$ 126.08 (1.00%)	55.44M
IVVDInvivyd Inc	US$ 2.335 (10.66%)	40.28M